Literature DB >> 21533785

Treatment with IP-10 induces host-protective immune response by regulating the T regulatory cell functioning in Leishmania donovani-infected mice.

Gaurav Gupta1, Saikat Majumdar, Anupam Adhikari, Parna Bhattacharya, Asok Kumar Mukherjee, Suchandra Bhattacharyya Majumdar, Subrata Majumdar.   

Abstract

Visceral leishmaniasis (VL), caused by the protozoan parasite, Leishmania donovani, is characterized by an infection in the liver and spleen. The failure of the first-line drugs has led to the development of new strategies for combating VL. Recently, our group has shown that interferon-γ-inducible protein (IP)-10, a CXC chemokine, renders protection against VL. In the present study, we have elucidated the mechanism by which IP-10 renders protection in in vivo L. donovani infection. We observed that IP-10-treated parasitized BALB/c mice showed a strong host-protective T helper cell (Th) 1 immune response along with marked decrease in immunosuppressive cytokines, tumor growth factor (TGF)-β, and interleukin (IL)-10 secreting CD4(+) T cells. This IP-10-mediated decrease in immunosuppressive cytokines was correlated with the reduction in the elevated frequency of CD4(+)CD25(+) T regulatory (Treg) cells along with the reduced TFG-β production from these Treg cells in Leishmania-infected mice. This reduction in TGF-β production was due to effective modulation of TGF-β signaling by IP-10, which reduced the immunosuppressive activity of Treg cells. Thus, these findings put forward a detailed mechanistic insight into IP-10-mediated regulation of the Treg cell functioning during experimental VL, which might be helpful in combating Leishmania-induced pathogenesis. © Springer-Verlag 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21533785     DOI: 10.1007/s00430-011-0197-y

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  55 in total

Review 1.  Role of chemokines in the biology of natural killer cells.

Authors:  Michael J Robertson
Journal:  J Leukoc Biol       Date:  2002-02       Impact factor: 4.962

2.  Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases.

Authors:  Gilles Boschetti; Stéphane Nancey; Fatima Sardi; Xavier Roblin; Bernard Flourié; Dominique Kaiserlian
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

3.  TNF-alpha and the IFN-gamma-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma.

Authors:  M Enderlin; E V Kleinmann; S Struyf; C Buracchi; A Vecchi; R Kinscherf; F Kiessling; S Paschek; S Sozzani; J Rommelaere; J J Cornelis; J Van Damme; C Dinsart
Journal:  Cancer Gene Ther       Date:  2008-08-01       Impact factor: 5.987

4.  T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.

Authors:  Ming O Li; Yisong Y Wan; Richard A Flavell
Journal:  Immunity       Date:  2007-05-03       Impact factor: 31.745

Review 5.  TGFbeta1 and Treg cells: alliance for tolerance.

Authors:  Ramireddy Bommireddy; Thomas Doetschman
Journal:  Trends Mol Med       Date:  2007-10-30       Impact factor: 11.951

6.  Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia.

Authors:  Miroslaw J Szczepanski; Marta Szajnik; Malgorzata Czystowska; Magis Mandapathil; Laura Strauss; Ann Welsh; Kenneth A Foon; Theresa L Whiteside; Michael Boyiadzis
Journal:  Clin Cancer Res       Date:  2009-05-05       Impact factor: 12.531

7.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.

Authors:  Gareth J Inman; Francisco J Nicolás; James F Callahan; John D Harling; Laramie M Gaster; Alastair D Reith; Nicholas J Laping; Caroline S Hill
Journal:  Mol Pharmacol       Date:  2002-07       Impact factor: 4.436

8.  Leishmania major: infection of human monocytes induces expression of IL-8 and MCAF.

Authors:  R Badolato; D L Sacks; D Savoia; T Musso
Journal:  Exp Parasitol       Date:  1996-01       Impact factor: 2.011

9.  Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells.

Authors:  Simona Stäger; Asher Maroof; Soombul Zubairi; Stephanie L Sanos; Manfred Kopf; Paul M Kaye
Journal:  Eur J Immunol       Date:  2006-07       Impact factor: 5.532

10.  CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis.

Authors:  Charles F Anderson; Mohammed Oukka; Vijay J Kuchroo; David Sacks
Journal:  J Exp Med       Date:  2007-02-05       Impact factor: 14.307

View more
  18 in total

1.  Mechanisms of immune evasion in leishmaniasis.

Authors:  Gaurav Gupta; Steve Oghumu; Abhay R Satoskar
Journal:  Adv Appl Microbiol       Date:  2013       Impact factor: 5.086

2.  Immunomodulation of host-protective immune response by regulating Foxp3 expression and Treg function in Leishmania-infected BALB/c mice: critical role of IRF1.

Authors:  Bidisha Paul Chowdhury; Shibali Das; Saikat Majumder; Kuntal Halder; Sweta Ghosh; Satabdi Biswas; Syamdas Bandyopadhyay; Subrata Majumdar
Journal:  Pathog Dis       Date:  2015-08-21       Impact factor: 3.166

3.  The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection.

Authors:  Allison Ehrlich; Tiago Moreno Castilho; Karen Goldsmith-Pestana; Wook-Jin Chae; Alfred L M Bothwell; Tim Sparwasser; Diane McMahon-Pratt
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

Review 4.  Whole blood assay and visceral leishmaniasis: Challenges and promises.

Authors:  Om Prakash Singh; Shyam Sundar
Journal:  Immunobiology       Date:  2014-01-31       Impact factor: 3.144

5.  Lipopolysaccharide engineering in Neisseria meningitidis: structural analysis of different pentaacyl lipid A mutants and comparison of their modified agonist properties.

Authors:  Elder Pupo; Hendrik-Jan Hamstra; Hugo Meiring; Peter van der Ley
Journal:  J Biol Chem       Date:  2014-02-03       Impact factor: 5.157

6.  Combination of Mycobacterium indicus pranii and Heat-Induced Promastigotes Cures Drug-Resistant Leishmania Infection: Critical Role of Interleukin-6-Producing Classical Dendritic Cells.

Authors:  Somaditya Dey; Debarati Mukherjee; Sirin Salma Sultana; Suvadip Mallick; Aritri Dutta; Joydip Ghosh; Aabid Hussain; Biswajyoti Sarkar; Supratim Mandal; Pradyumna Patra; Bhaskar Saha; Chiranjib Pal
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

7.  Interferon gamma in leishmaniasis.

Authors:  Peter E Kima; Lynn Soong
Journal:  Front Immunol       Date:  2013-06-19       Impact factor: 7.561

8.  CXCL10 is critical for the generation of protective CD8 T cell response induced by antigen pulsed CpG-ODN activated dendritic cells.

Authors:  Saikat Majumder; Surajit Bhattacharjee; Bidisha Paul Chowdhury; Subrata Majumdar
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

9.  Antigen-Pulsed CpG-ODN-Activated Dendritic Cells Induce Host-Protective Immune Response by Regulating the T Regulatory Cell Functioning in Leishmania donovani-Infected Mice: Critical Role of CXCL10.

Authors:  Saikat Majumder; Amrita Bhattacharjee; Bidisha Paul Chowdhury; Suchandra Bhattacharyya Majumdar; Subrata Majumdar
Journal:  Front Immunol       Date:  2014-06-04       Impact factor: 7.561

10.  Deficiency of p110δ isoform of the phosphoinositide 3 kinase leads to enhanced resistance to Leishmania donovani.

Authors:  Forough Khadem; Zhirong Mou; Dong Liu; Sanjay Varikuti; Abhay Satoskar; Jude E Uzonna
Journal:  PLoS Negl Trop Dis       Date:  2014-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.